Along with the Society for Immunotherapy of Cancer we strive for a future #Immune2Cancer because to our team, cancer immunotherapy research is personal. Our scientists are researching potential, new cancer treatment options for our loved ones and yours.
This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.
Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.
June 2, 2020 /3BL Media/ - The UPS Foundation, which leads the global citizenship programs for UPS (NYSE: UPS), and Gavi, the Vaccine Alliance, announced today a commitment of US$3 million in new funding and in-kind logistics support spanning two years, provided by UPS and The UPS Foundation to Gavi.
It took a pandemic to break down barriers to innovation. Is this wave of ingenuity here to stay?
No individual, industry, or country was ready for coronavirus. Traditional systems continue to buckle under the strains of disruption, forcing years of change in a matter of months. Every day, doctors and nurses don their armor of latex, plexiglass, and cotton. They're backed by supporters big and small: from manufacturing and healthcare companies to parents-turned-mask-makers, and 3D printing entrepreneurs.
In times of disbelief, that’s when beliefs matter most.
As 2019 came to a close and a new decade commenced, January’s Lunar New Year celebrations across China came to a screeching halt. The novel coronavirus had taken hold. By late March, COVID-19 had infected more than 786,0001 people globally, and a headline became every conversation the world over. Shortages of protective medical gear, hospital beds, staff, and answers left little room for a plan, leaving doctors and nurses working bed to bed, moment to moment.